BRIEF published on 07/22/2025 at 09:05, 4 months 13 days ago Gut Microbiome: A Potential Early Indicator of Dementia Risk Early Detection Screening Tools Gut Microbiome Dementia Risk MCI Prediction
PRESS RELEASE published on 07/22/2025 at 09:00, 4 months 13 days ago Study Findings Reveal: Gut Microbiome May Offer Early Insight into Dementia Risk Study reveals gut microbiome may offer early insight into dementia risk, potentially leading to screening tools for routine diagnostics and early interventions. SYNLAB expert co-authors findings Alzheimer's Disease Early Detection SYNLAB Gut Microbiome Dementia Risk
BRIEF published on 07/01/2025 at 09:05, 5 months 3 days ago VαMPiRE Project Makes Strides in Parkinson’s Detection EU Funding Parkinson’s Detection VαMPiRE Project SYNLAB Diagnostics Α-synuclein Biomarkers
PRESS RELEASE published on 07/01/2025 at 09:00, 5 months 3 days ago Milestone Reached in Groundbreaking Project for Early Detection of Parkinson’s Disease SYNLAB reaches a milestone in the VαMPiRE project funded by the EU, focusing on early Parkinson's disease detection with advanced genomics and €8 million funding Parkinson's Disease Diagnostic Test EU Funding SYNLAB VαMPiRE Project
BRIEF published on 10/30/2024 at 07:37, 1 year 1 month ago Cinven Acquires Elliott's Stake in SYNLAB AG with Squeeze-Out Imminent Private Equity Squeeze-out SYNLAB AG Cinven Elliott Advisors
PRESS RELEASE published on 10/30/2024 at 07:32, 1 year 1 month ago Cinven to Acquire Elliott’s Stake in SYNLAB AG, Squeeze-Out to Follow Cinven acquires Elliott's stake in SYNLAB AG, squeeze-out procedure initiated. SYNLAB's Management Board informed. Ephios Bidco to hold over 96% share capital Private Equity SYNLAB AG Cinven Elliott Squeeze Out
BRIEF published on 09/17/2024 at 16:05, 1 year 2 months ago Cinven to Sell Minority Stake in SYNLAB to Labcorp Investment SYNLAB Cinven Labcorp Minority Stake
PRESS RELEASE published on 09/17/2024 at 16:00, 1 year 2 months ago Cinven to sell minority stake in SYNLAB to strategic investor Labcorp Cinven agrees to sell 15% stake in SYNLAB to Labcorp, a global leader in laboratory services. Transaction aims to enhance lab efficiency and customer experience Strategic Investor Medical Diagnostics SYNLAB Cinven Labcorp
BRIEF published on 06/04/2024 at 20:51, 1 year 6 months ago Cybersecurity Incident at Synnovis in UK Cybersecurity SYNLAB Synnovis NHS England Impact
PRESS RELEASE published on 06/04/2024 at 20:46, 1 year 6 months ago Cybersecurity Incident at Synnovis in UK SYNLAB AG confirms cybersecurity incident at Synnovis in the UK, isolated from previous attacks. Taskforce working to assess impact and minimize disruptions for patients and partners SYNLAB AG Synnovis NHS England Cybersecurity Incident Patient Impact
Published on 12/05/2025 at 02:35, 3 hours 28 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 3 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 58 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 3 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 33 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 12 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 38 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 48 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 52 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 3 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 18 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 19 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 2 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
